• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TUTOGEN MEDICAL GMBH FORTIVA PROCINE DERMIS; PORCINE DERMAL TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TUTOGEN MEDICAL GMBH FORTIVA PROCINE DERMIS; PORCINE DERMAL TISSUE Back to Search Results
Catalog Number PD3030
Device Problem Contamination (1120)
Patient Problems Wound Dehiscence (1154); Hernia (2240)
Event Date 09/30/2014
Event Type  Injury  
Event Description
Rti surgical, inc.(rti) and tutogen medical (b)(4), a wholly owned subsidiary of rti received a complaint on (b)(6) 2014 reporting that a patient underwent a difficult small bowel repair, a contaminated wound site, with abdominal wall reconstruction utilizing a fortiva graft on (b)(6) 2014.The patient was readmitted on (b)(6) 2014 due to the development of wound dehiscence with graft degradation noted.Medical records were requested but not received.
 
Manufacturer Narrative
Method: graft was not returned to rti for evaluation, therefore, a re-review was performed of the manufacturing records, sterilization run reports, environmental monitoring results, quality control/assurance reviews and release, and the complaint database for related complaints associated with the lot.Results: no deviations were noted during the records re-review for lot# mp130701.The graft underwent a validated sterilization; tutoplast which includes terminal sterilization by gama irradiation after packaging.To date, rti has distributed (b)(4) xenografts from the lot and distributed (b)(4) without related complaints.Environmental data and records generated during and around the time of processing for lot# mp130701 were acceptable.Conclusion: given that (1) no deviations were noted in records re-review, graft id (b)(6) manufactured to specification prior to distribution, and (2) per physician report in the complaint notification, the graft was utilized in a contaminated wound site, it is more plausible that the patient's outcome and complications were associated with a source or event extrinsic to the xenograft implant.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FORTIVA PROCINE DERMIS
Type of Device
PORCINE DERMAL TISSUE
Manufacturer (Section D)
TUTOGEN MEDICAL GMBH
neunkirchen
GM 
Manufacturer (Section G)
TUTOGEN MEDICAL GMBH
Manufacturer Contact
leila diaz
11621 research circle
alachua, FL 32615
3864188888
MDR Report Key4339861
MDR Text Key5198482
Report Number3002924436-2014-00005
Device Sequence Number1
Product Code FTM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K081538
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 11/13/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/12/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/24/2016
Device Catalogue NumberPD3030
Device Lot NumberMP130701
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/13/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
NOT PROVIDED
Patient Outcome(s) Required Intervention;
Patient Age53 YR
-
-